EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Mesenchymal stem cells - the secret agents of cancer immunotherapy: Promises, challenges, and surprising twists

Theia Minev, Shani Balbuena, Jaya Mini Gill, Francesco M Marincola, Santosh Kesari, Feng Lin

Oncotarget · 2024

DOI: 10.18632/oncotarget.28672 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Oncotarget, 2024. Verfasst von Theia Minev und 5 weiteren Autor:innen. Beteiligte Einrichtung: CureScience Institute, San Diego, CA 92121, USA. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Neoplasms, Tumor Microenvironment, Mesenchymal Stem Cell Transplantation. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mesenchymal stem cells (MSCs) are recognized for their immunomodulatory capabilities, tumor-homing abilities, and capacity to serve as carriers for therapeutic agents. This review delves into the role of adoptively transferred MSCs in tumor progression, their interactions with the tumor microenvironment, and their use in delivering anti-cancer drugs, oncolytic viruses, and genetic material. It also addresses the challenges and limitations associated with MSC therapy, such as variability in MSC preparations and potential tumorigenic effects emphasizing the need for advanced genetic engineering and personalized approaches to enhance therapeutic efficacy. The review concludes with an optimistic outlook on the future of MSC-based therapies, underscoring their promise to develop effective and personalized cancer treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsNeoplasmsTumor MicroenvironmentMesenchymal Stem Cell TransplantationImmunotherapyHumansAnimals

Stichwörter der Autor:innen

cancer immunotherapygenetic engineeringmesenchymal stem cell homingmesenchymal stem cellsstem cell delivery

Autor:innen und Institutionen

  • CureScience Institute, San Diego, CA 92121, USA.
  • Sonata Therapeutics, Boston, MA 02472, USA.
  • Department of Translational Neurosciences, Pacific Neuroscience Institute and Providence Saint John's Health Center, Saint John's Cancer Institute, Santa Monica, CA 90404, USA.

Zitieren

APA

Minev, T., Balbuena, S., Gill, J. M., Marincola, F. M., Kesari, S., & Lin, F. (2024). Mesenchymal stem cells - the secret agents of cancer immunotherapy: Promises, challenges, and surprising twists. Oncotarget. https://doi.org/10.18632/oncotarget.28672

Vancouver

Minev T, Balbuena S, Gill JM, Marincola FM, Kesari S, Lin F. Mesenchymal stem cells - the secret agents of cancer immunotherapy: Promises, challenges, and surprising twists. Oncotarget. 2024. doi:10.18632/oncotarget.28672

BibTeX
@article{Minev2024,
  author = {Minev, Theia and Balbuena, Shani and Gill, Jaya Mini and Marincola, Francesco M and Kesari, Santosh and Lin, Feng},
  title = {Mesenchymal stem cells - the secret agents of cancer immunotherapy: Promises, challenges, and surprising twists},
  journal = {Oncotarget},
  year = {2024},
  doi = {10.18632/oncotarget.28672}
}
Kostenlos starten →